Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
RElaziONi<br />
Pineal parenchymal tumors<br />
S. Rossi<br />
Ospedale Regionale di Treviso<br />
This presentation focuses on the classification and grading of<br />
pineal parenchymal tumors and includes a discussion on the<br />
differential diagnosis with the other entities encountered in<br />
the pineal region.<br />
Pineal parenchymal tumors are histogenetically linked to the<br />
pineocyte, which is a cell with photosensory and neuroendocrine<br />
functions. During the late stages of the intrauterine life<br />
and the early post-natal period, the pineal gland consists of rosettes<br />
with abundant melanin and cilia, similar to those of the<br />
developing retina. Progressively the pigmented cells decrease<br />
and NSE-positive pineocytes accumulate, by post-natal age<br />
of 1 year representing the predominant cells. To some extent,<br />
the pineal parenchymal tumors mimic the developmental<br />
stages of the pineal gland, since they constitute a morphologic<br />
continuum from the most mature pineal tumor (pineocytoma<br />
WHO grade I) to pineal parenchymal tumors of intermediate<br />
differentiation (PPTIDs; further stratified into WHO grades II<br />
or III) to the highly aggressive small round cell tumor, pineoblastoma<br />
(WHO grade IV) somewhat reminiscent of the fetal<br />
pineal gland. Coherently, pineal tumors tend to express synaptophysin,<br />
NSE and neurofilament from diffusely in the more<br />
mature tumor forms to focally in pineoblastoma. They also<br />
may express neuronal markers and retinal S-antigen. These<br />
tumors may compress adjacent structures including the cerebral<br />
aqueduct, brain stem, and cerebellum. Signs and symptoms<br />
therefore relate to obstructive hydrocephalus, increased<br />
intracranial pressure and neuro-ophthalmologic dysfunction<br />
(Parinaud syndrome). On magnetic resonance imaging, they<br />
are T2 bright with contrast enhancement on post-gadolinium<br />
T1 sequences.<br />
PINEOCYTOMA. At the most mature/differentiated end of<br />
the spectrum lies the pineocytoma (1,2). Most pineocytomas<br />
occur in adults. At low power, they are moderately cellular<br />
and feature a diffuse to loosely nested-growth pattern. At high<br />
power, they are composed of medium-sized neoplastic cells<br />
resembling mature pineocytes with round to oval nuclei and a<br />
delicate or “salt and pepper” chromatin. Pineocytomatous rosettes<br />
are a distinctive feature of pineocytomas, but they vary<br />
in number and size. These structures are composed of neuropil<br />
surrounded by neoplastic cells with non-regimented nuclei<br />
and club-shaped terminations oriented toward the center. Notably,<br />
some pineocytoma feature multinucleated/bizarre cells.<br />
PINEOBLASTOMA. At the most malignant end of the<br />
spectrum, lies the pineoblastoma, a WHO grade IV tumor<br />
which occurs commonly in children with a mean age of 12.6<br />
years 1 2 . They are accompanied by leptomeningeal seeding<br />
in as many as 45% of cases and rarely by extracranial metastases.<br />
Extent of disease at diagnosis, extent of resection and<br />
radiotherapy affect the prognosis. Histologically they resemble<br />
CNS PNET. At low power, they look as diffuse, highly<br />
cellular tumors sometimes featuring either Homer-Wright or<br />
Flexner-Wintersteiner rosettes. Interestingly, the presence of<br />
the Flexner-Wintersteiner, as well as the possible expression<br />
of the retinal S-antigen and the rare occurrence of the trilateral<br />
retinoblastoma syndrome indicate the ontogenic relation with<br />
the retinal cells. At high power, pineoblastomas are composed<br />
of round cells with scant cytoplasm and high nuclear/cytoplasmic<br />
ratio, with frequent molding, feature high mitotic activity<br />
and, often, necrosis. Desmoplastic foci and anaplastic cytology<br />
may be encountered. Interestingly, mixed tumors with<br />
207<br />
areas of pineocytoma and areas of pineoblastomas juxtaposed<br />
are seldom observed.<br />
PINEAL TUMORS OF INTERMEDIATE DIFFERENTIA-<br />
TION. In between the 2 extremes of differentiation, the pineal<br />
parenchymal tumor of intermediate differentiation has clearly<br />
been the most problematic category in terms of both classification<br />
and treatment 1 2 . The reported incidence of these<br />
tumors is highly variable reflecting the difficulties in establishing<br />
reproducible criteria. It was first introduced by Schild<br />
et al. In 1993 3 . PPTIDs can have 3 different morphologic<br />
subtypes: a lobulated pattern, a diffuse pattern mimicking<br />
oligodendroglioma or neurocytoma, and a transitional form<br />
with lobulated and/or diffuse architecture areas intermixed<br />
with regions containing pineocytoma-like regions featuring<br />
the typical rosettes. Sometimes, they feature a papillary architecture<br />
4 . The tumor cells in PPTIDs generally have less cytoplasm<br />
than pineocytomas and show moderate nuclear atypia.<br />
Mitotic index is variable (0 to 16 per 10 HPFs) The average<br />
Ki-67-labeling index is 10.1% (range: 8%-11.8%.<br />
On the base of Jouvet et al’s study 5 on PPTIDs and recently<br />
adopted by the WHO 1 , these tumors can further be divided<br />
in 2 subgroups although definite criteria have yet to be established.<br />
In general, low-grade PPTIDs (corresponding to WHO<br />
grade II) consist of transitional, lobulated, or diffuse growth<br />
patterns, strongly express neurofilament protein, and have<br />
fewer than 6 mitoses per 10 HPFs. High-grade PPTIDs (WHO<br />
grade III) consist of lobulated or diffuse growth patterns (ie,<br />
no pineocytoma-like regions) with 6 or more mitoses per 10<br />
HPFs and limited neurofilament immunostaining. The Ki-67labeling<br />
index is higher in the latter group. Focal necrosis,<br />
leptomeningeal infiltration, and vascular proliferation may<br />
also be observed.<br />
Differential diagnosis<br />
The main differential diagnoses of pineocytoma include normal<br />
pineal gland and pineal cyst. While the pineocytomas<br />
generally form sheets or expanded lobules, normal pineal<br />
gland has small lobules and well-formed fibrovascular septae.<br />
In the pineal cyst 3 layers are typically identified: piloid<br />
gliosis with numerous Rosenthal fibers, compressed pineal<br />
parenchyma, and leptomeningeal tissue.<br />
Regarding PPTID, other entities that may occur in the third<br />
ventricle come to the differential, the papillary tumor of the<br />
pineal region, ependymoma, oligondroglioma and germ cell<br />
tumors. The papillary tumor of the pineal region (PTPR)<br />
was first described as a distinct entity in 2003 by Jouvet<br />
et al. 6 and formally codified in the 2007 edition of WHO<br />
Classification of Tumours of the Central Nervous System 1 .<br />
PTPR arises exclusively in the pineal region and occurs most<br />
commonly in adults (mean, 31.5 years). PTPRs are usually<br />
well-circumscribed, large (2.5-4.0 cm) lesions sometimes<br />
cystic. Histologically, at low power, they feature discrete<br />
borders and consist of papillary areas and solid cellular<br />
areas in variable proportion. In the papillary component,<br />
vessels are often hyalinized and are covered by large, paleto-eosinophilic<br />
cells arranged in a pseudostratified columnar<br />
layering. The solid areas are composed of round to oval cells<br />
with eosinophilic/clear/vacuolated cytoplasm or with PASpositive<br />
inclusions variably arranged in pseudorosettes/true<br />
rosettes/tubules. Pleomorphic nuclei may be seen in some<br />
cases. Mitotic activity varies, ranging from 0 to 10 mitoses<br />
per 10 HPF. Necrosis is usually found to some extent in most<br />
tumors. Fevre-Montange et al. 7 reviewed the prognosis of<br />
PTRP. Detailed follow-up information was obtained in 29 of<br />
31 cases. Five-year estimates of overall and progression-free<br />
survival were 73% and <strong>27</strong>%, respectively. Seven patients